Caldera Medical acquires Irish pelvic health company Atlantic Therapeutics

The US women’s health medical device company Caldera Medical has acquired the Irish pelvic health company Atlantic Therapeutics.

Atlantic Therapeutics specialises in the development of medical devices, related software, and connected health technologies for treating incontinence, sexual health dysfunctions, and other related disorders.

The company produces pelvic floor strengthening and nerve stimulating solutions for women and is behind the Innovo shorts, a wearable, home-based urinary incontinence treatment.

Urinary incontinence is a highly prevalent condition that results in significant morbidity.

It is thought that around one in three women will have ongoing, problematic stress urinary incontinence. However, less than half of women who suffer seek treatment resulting in a significant proportion of clinically relevant urinary incontinence remaining undiagnosed.

By acquiring Atlantic Therapeutics, Caldera Medical says it will add the FDA-cleared incontinence treatment as a first-line therapy for women with stress urinary incontinence, helping more people strengthen their pelvic health and restore their bladder control.

Bryon Merade, CEO of Caldera Medical, said: “We are thrilled to acquire Atlantic Therapeutics and scale the rapidly growing Innovo products worldwide.

“This acquisition aligns perfectly with our mission and allows us to offer an even more comprehensive suite of solutions to healthcare providers and patients alike.”

Susan Trent, CEO of Atlantic Therapeutics, said: “Since its formation, the team at Atlantic Therapeutics has demonstrated the huge potential of Innovo.

“This unique technology with robust clinical data is ideally placed to serve the millions of women worldwide who suffer the daily distress of SUI.

“Caldera Medical’s ability to maximise this potential is the perfect next step. I am delighted that we will see Innovo thrive within Caldera Medical and want to thank Bryon and the team for their dedication to women’s health.”